Subtopic Deep Dive
Triptolide and Transcriptional Inhibition
Research Guide
What is Triptolide and Transcriptional Inhibition?
Triptolide is a diterpenoid triepoxide from Tripterygium wilfordii that inhibits eukaryotic transcription by covalently binding XPB, a subunit of TFIIH, yielding anti-cancer and anti-inflammatory effects.
Triptolide targets XPB to halt RNA polymerase II-mediated transcription elongation (Titov et al., 2011, 503 citations). This mechanism underlies its broad therapeutic potential in cancer and inflammation (Qiu and Kao, 2003, 308 citations). Over 50 papers document its isolation, specificity, and toxicity profiles since 2001.
Why It Matters
Triptolide's XPB inhibition blocks transcription in proliferating cells, offering broad anti-cancer activity without resistance via target mutation (Titov et al., 2011). In inflammation, it suppresses IL-2 and NF-κB pathways, providing immunosuppression for autoimmune diseases (Qiu et al., 1999; Chen, 2001). Clinical translation faces toxicity hurdles, but combinations enhance efficacy (Tan et al., 2011; Chen et al., 2018). Bensaude (2011) evaluates transcription inhibitors like triptolide for nuclear structure changes and paradoxical gene activation.
Key Research Challenges
Narrow Therapeutic Window
Triptolide's potency causes off-target toxicity limiting clinical doses (Chen, 2001, 302 citations). Balancing XPB inhibition efficacy against normal cell damage requires specificity enhancers (Chen et al., 2018). Dose optimization studies show variable responses across cell types.
Mechanism Specificity Confirmation
Distinguishing direct XPB binding from secondary effects demands advanced assays (Titov et al., 2011, 503 citations). Bensaude (2011) stresses evaluating true transcription inhibition versus nuclear artifacts. Paradoxical gene stimulation complicates readout interpretation.
Combinatorial Therapy Optimization
Synergy with chemotherapy needs systematic screening for resistance reversal (Tan et al., 2011, 394 citations). Triptolide enhances apoptosis but risks additive toxicity (Khan et al., 2019). Predictive models for polypharmacology remain underdeveloped.
Essential Papers
Inhibiting eukaryotic transcription. Which compound to choose? How to evaluate its activity?
Olivier Bensaude · 2011 · Transcription · 584 citations
This review first discusses ways in which we can evaluate transcription inhibition, describe changes in nuclear structure due to transcription inhibition, and report on genes that are paradoxically...
XPB, a subunit of TFIIH, is a target of the natural product triptolide
Denis V. Titov, Benjamin Gilman, Qingli He et al. · 2011 · Nature Chemical Biology · 503 citations
Anti-cancer natural products isolated from chinese medicinal herbs
Wen Tan, Jin‐Jian Lu, Mingqing Huang et al. · 2011 · Chinese Medicine · 394 citations
Abstract In recent years, a number of natural products isolated from Chinese herbs have been found to inhibit proliferation, induce apoptosis, suppress angiogenesis, retard metastasis and enhance c...
Anticancer Plants: A Review of the Active Phytochemicals, Applications in Animal Models, and Regulatory Aspects
Tariq Khan, Muhammad Ali, Ajmal Khan et al. · 2019 · Biomolecules · 353 citations
The rising burden of cancer worldwide calls for an alternative treatment solution. Herbal medicine provides a very feasible alternative to western medicine against cancer. This article reviews the ...
A Mechanistic Overview of Triptolide and Celastrol, Natural Products from Tripterygium wilfordii Hook F
Shaoru Chen, Yan Dai, J. Zhao et al. · 2018 · Frontiers in Pharmacology · 323 citations
Triptolide and celastrol are predominantly active natural products isolated from the medicinal plant <i>Tripterygium wilfordii</i> Hook F. These compounds exhibit similar pharmacological activities...
Immunosuppressive and Anti-Inflammatory Mechanisms of Triptolide, the Principal Active Diterpenoid from the Chinese Medicinal Herb Tripterygium wilfordii Hook. f.
Daoming Qiu, Peter N. Kao · 2003 · Drugs in R&D · 308 citations
Triptolide, A Novel Immunosuppressive and Anti-Inflammatory Agent Purified from a Chinese Herb Tripterygium Wilfordii Hook F
Benny J. Chen · 2001 · Leukemia & lymphoma/Leukemia and lymphoma · 302 citations
Triptolide is a diterpenoid triepoxide purified from a Chinese herb Tripterygium Wilfordii Hook F (TWHF). TWHF has been used in traditional Chinese medicine for more than two thousand years. Howeve...
Reading Guide
Foundational Papers
Start with Titov et al. (2011, 503 citations) for XPB mechanism discovery, then Bensaude (2011, 584 citations) for transcription inhibition evaluation methods, followed by Chen (2001, 302 citations) for clinical context.
Recent Advances
Chen et al. (2018, 323 citations) mechanistically overviews triptolide-celastrol; Khan et al. (2019, 353 citations) reviews anticancer applications in models.
Core Methods
XPB covalent binding assays, nuclear run-on transcription, Pol II Ser2/Ser5 phosphorylation Westerns, NF-κB luciferase reporters (Titov 2011; Bensaude 2011; Qiu 1999).
How PapersFlow Helps You Research Triptolide and Transcriptional Inhibition
Discover & Search
Research Agent uses searchPapers and citationGraph to map 50+ triptolide papers from Titov et al. (2011), revealing XPB-TFIIH clusters and downstream inflammation links. exaSearch uncovers combinatorial studies; findSimilarPapers expands from Bensaude (2011) to 584-cited transcription inhibitors.
Analyze & Verify
Analysis Agent applies readPaperContent to extract XPB binding kinetics from Titov et al. (2011), then verifyResponse with CoVe checks claims against Qiu et al. (2003). runPythonAnalysis processes dose-response curves via pandas/matplotlib for IC50 stats; GRADE scores evidence strength for clinical translation.
Synthesize & Write
Synthesis Agent detects gaps in toxicity mitigation post-Titov (2011), flags NF-κB contradictions between Qiu (1999) and Chen (2001). Writing Agent uses latexEditText, latexSyncCitations for 20-paper reviews, latexCompile mechanisms diagrams, exportMermaid for XPB-TFIIH pathways.
Use Cases
"Analyze triptolide IC50 data across cancer cell lines from 10 papers"
Research Agent → searchPapers('triptolide IC50 cancer') → Analysis Agent → readPaperContent(Titov 2011) → runPythonAnalysis(pandas aggregation, matplotlib plots) → CSV export of mean IC50 by cell type.
"Draft LaTeX review on triptolide XPB mechanism with citations"
Synthesis Agent → gap detection(Titov 2011 + Bensaude 2011) → Writing Agent → latexEditText(structured sections) → latexSyncCitations(20 papers) → latexCompile → PDF with TFIIH pathway figure.
"Find code for triptolide molecular dynamics simulations"
Research Agent → paperExtractUrls(Titov 2011 similar) → Code Discovery → paperFindGithubRepo → githubRepoInspect → runPythonAnalysis(GROMACS scripts) → validated simulation protocol.
Automated Workflows
Deep Research workflow scans 250M+ papers via OpenAlex for triptolide-TFIIH, yielding structured report with GRADE-scored evidence chains from Titov (2011) to Chen (2018). DeepScan's 7-step analysis verifies XPB specificity with CoVe checkpoints on Qiu (2003). Theorizer generates hypotheses for triptolide-celastrol combinations from citationGraph.
Frequently Asked Questions
What defines triptolide's transcriptional inhibition?
Triptolide covalently binds XPB in TFIIH, stalling RNA Pol II elongation (Titov et al., 2011).
What methods evaluate triptolide activity?
Assays measure nuclear run-on transcription, Pol II CTD phosphorylation, and XPB ATPase inhibition; Bensaude (2011) details controls for artifacts.
What are key papers on triptolide?
Titov et al. (2011, 503 citations) identifies XPB target; Qiu and Kao (2003, 308 citations) covers mechanisms; Chen (2001, 302 citations) establishes immunosuppressive role.
What open problems exist?
Toxicity reduction via derivatives, specificity beyond XPB, and combinatorial regimens need clinical validation (Chen et al., 2018).
Research Natural Compounds in Disease Treatment with AI
PapersFlow provides specialized AI tools for Medicine researchers. Here are the most relevant for this topic:
Systematic Review
AI-powered evidence synthesis with documented search strategies
AI Literature Review
Automate paper discovery and synthesis across 474M+ papers
Find Disagreement
Discover conflicting findings and counter-evidence
Paper Summarizer
Get structured summaries of any paper in seconds
See how researchers in Health & Medicine use PapersFlow
Field-specific workflows, example queries, and use cases.
Start Researching Triptolide and Transcriptional Inhibition with AI
Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.
See how PapersFlow works for Medicine researchers